Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

NCT06818565 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Acute-On-Chronic Liver Failure

Interventions

DRUG: Meropenem Injection
DRUG: Ceftazidime-avibactam
DRUG: Teicoplanin

Sponsor

Institute of Liver and Biliary Sciences, India